Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance
about
Human genetic disorders and knockout mice deficient in glycosaminoglycanRequirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor XMammalian protein glycosylation--structure versus function.Insulin-dependent diabetes mellitus in mice does not alter liver heparan sulfateHepcidin antagonists for potential treatments of disorders with hepcidin excess.Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in miceDeletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humansGlycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systemsSyndecan-1 is required to maintain intradermal fat and prevent cold stress.Modifications of glycans: biological significance and therapeutic opportunitiesRole of heparan sulfate proteoglycans in optic disc and stalk morphogenesisType 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteinsHeparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate.Genetic analysis of the heparan modification network in Caenorhabditis elegansGenetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjectsStage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling.Heparan sulfate proteoglycans.Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal InfectionThe glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development.Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice.Role of glycosaminoglycans in infectious diseaseGlucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks.Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycansGlycosaminoglycans and infection.Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in miceMeta-analysis identifies gene-by-environment interactions as demonstrated in a study of 4,965 mice.The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.Genetic risk variants for metabolic traits in Arab populationsA new, powerful player in lipoprotein metabolism: brown adipose tissue.Hyperlipoproteinemia type 3: the forgotten phenotype.The role of heparan sulphate in development: the ectodermal story.Changes in expression of proteoglycan core proteins and heparan sulfate enzymes in the developing and adult murine aortaAdvances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.
P2860
Q26995332-9F406835-B599-4996-B0AC-D7A2A75877F9Q28475714-A10C8820-1C2F-44FE-B6AD-264F9967CEAEQ33358345-EB423467-C026-48A0-A645-5C3D1F9D792DQ33541795-76202A8A-C920-4486-BF2E-1332677A0F43Q33563777-11E44B54-DD50-4D74-BE7D-5D007D7F9B8FQ33587338-E3CA6DEC-9F82-46BA-BFA1-28C4AE834B25Q33750290-F393A5F0-8A11-4AF6-AD64-01751B8360FCQ33951943-DDD26390-09B6-4BAE-9DFA-580AAD10E9B2Q34015240-65B318D7-A0BD-4B6A-BACF-3ABD272BD8A8Q34111293-2A204F85-ABFF-4CCA-B774-302914138E75Q34254879-01C100A6-81E7-475F-B987-B1B20970640AQ34348377-21B72BD6-66FB-4D3F-AB5F-ADEEB916864DQ34452740-04490E17-BA21-42B9-803B-16DA4E0B798DQ34800351-8961E432-BF09-455C-8EEB-6519CBF8A8D1Q34947657-B8905535-002B-4BDE-AACE-43CB86D31A10Q35053168-C6B07C36-60E4-417A-B83A-3ECD3BE3727CQ35056355-AAEE1E42-5BE3-4355-8835-7861BC69E477Q35059448-8249023F-8DBB-40D2-A9F1-72AD27A2B71BQ35120945-0449F7AE-DAF1-4165-B329-132D7FCFB392Q35631767-7B41A51E-2DB6-4AD4-A0E4-DF0C9A7C5008Q35783119-B87146FC-E8FA-4344-997C-2ADDD0727777Q35955763-506E4E5E-9032-4A13-9EE6-F58F337C6206Q36084654-9295D87E-3D37-4ECB-A78B-CA0E3B58FFA4Q36194268-9D2E443E-2CB9-4F3F-9D4B-CD621334F99FQ36220338-A07A1F2D-CD30-4FCD-8F1C-7626E7FD6E63Q36513995-F55B11C8-E9E4-42B5-A55F-84C3136C8A55Q36891073-1F8A0F89-E0A6-4E97-B9B5-51BB1EE37C02Q37155849-EDD969CE-952C-43A8-95CF-D074F4ED47E6Q37292212-E97587B7-02AA-4B1C-B34E-3F88016409E2Q37458267-0B3938E7-311C-46F0-BBD4-07674CB067A3Q37584881-2E3268EF-3013-4C33-B2B8-58BA75DCEA9DQ37595238-2B755D31-83CA-40E1-81F1-041C43A3A9BCQ37974566-477C0A21-0624-41A7-A762-5D83A38AECA7Q38235600-A84399AA-0153-4F27-83E1-3B62D0CD11EAQ38888282-AFC1923D-247B-48CD-84BD-603217F7FD73Q40989712-6A4AD370-92C3-4C8F-B370-6A753CF20FA6Q46128938-B7B3EFE8-FCB1-4291-8478-4773014AEDB4
P2860
Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Heparan sulfate 2-O-sulfotrans ...... ide-rich lipoprotein clearance
@ast
Heparan sulfate 2-O-sulfotrans ...... ide-rich lipoprotein clearance
@en
Heparan sulfate 2-O-sulfotrans ...... de-rich lipoprotein clearance.
@nl
type
label
Heparan sulfate 2-O-sulfotrans ...... ide-rich lipoprotein clearance
@ast
Heparan sulfate 2-O-sulfotrans ...... ide-rich lipoprotein clearance
@en
Heparan sulfate 2-O-sulfotrans ...... de-rich lipoprotein clearance.
@nl
prefLabel
Heparan sulfate 2-O-sulfotrans ...... ide-rich lipoprotein clearance
@ast
Heparan sulfate 2-O-sulfotrans ...... ide-rich lipoprotein clearance
@en
Heparan sulfate 2-O-sulfotrans ...... de-rich lipoprotein clearance.
@nl
P2093
P2860
P356
P1476
Heparan sulfate 2-O-sulfotrans ...... ide-rich lipoprotein clearance
@en
P2093
Danyin Song
Hiroko Habuchi
Jan Castagnola
Jeffrey D Esko
Jillian R Brown
Joseph R Bishop
Koji Kimata
Kristin I Stanford
Lianchun Wang
Masakazu Tanaka
P2860
P304
P356
10.1074/JBC.M109.063701
P407
P577
2009-11-04T00:00:00Z